Clinical trial · Interventional
Randomized Controlled Trial of Integrated Early Palliative Care
Randomized Controlled Trial of Integrated Early Palliative Care for Advanced Cancer Patients
NCT03181854CI-TRIAL-00039901completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study verifies whether integrated Early Palliative Care for advanced cancer patients diagnosed due to a solid tumor improve quality of life and enhances the ability to overcome the current crisis.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Cancer | Malignant Neoplasm | CURATED_BROADER | 0.78 |
| Solid Tumor | Solid Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Consultation with PCT doctor | Behavioral | — | UNRESOLVED |
| Telephone coaching | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention group
- description
- Consultation with PCT doctor every 3 weeks. Telephone coaching once a week for 3 months and once in 2 weeks for another 3 months.
- interventionNames
- Behavioral: Telephone coaching
- Behavioral: Consultation with PCT doctor
- type
- NO_INTERVENTION
- label
- Control Group
- description
- Usual palliative care can be provided if desired.
Primary outcomes (1)
- measure
- Change in level of EORTC QLQ-C15-PAL
- timeFrame
- baseline, 12 weeks, 18 weeks, 24 weeks
- description
- A questionnaire developed to assess the quality of life of palliative cancer care patients.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: * Subject 20 years and older. * Subject who has an advanced cancer diagnosis (histologically or cytologically confirmed) due to a solid tumor * Subject whose ECOG performance status is between 0 to 2. * Subject with an estimated life expectancy of 12 months and less (assessed by the treating oncologist) * Subject who volunteers Exclusion Criteria: * Inability to speak, understand or write Korean. * Medical conditions that would limit adherence to participation of the clinical trial(as confirmed by their referring physician; e.g. dyspnea) * Suspension of all cancer treatment * Palliative care consultation at any time or in palliative care
References
Publications (2)
- DERIVEDJung JY, Yun JY, Kang JH, Koh SJ, Kim YJ, Seo S, Kim JH, Cheon J, Kang EJ, Song EK, Nam EM, Oh HS, Choi HJ, Kwon JH, Bae WK, Lee JE, Jung KH, Kang E, Yun YH. Interaction effect of comorbid depression and proactive positivity coping strategy on the 1-year survival of patients with advanced cancer: a nationwide multicentre study in South Korea. BMC Psychiatry. 2025 Jun 2;25(1):565. doi: 10.1186/s12888-025-06972-4. PMID 40457290
- DERIVEDKang E, Kang JH, Koh SJ, Kim YJ, Seo S, Kim JH, Cheon J, Kang EJ, Song EK, Nam EM, Oh HS, Choi HJ, Kwon JH, Bae WK, Lee JE, Jung KH, Yun YH. Early Integrated Palliative Care in Patients With Advanced Cancer: A Randomized Clinical Trial. JAMA Netw Open. 2024 Aug 1;7(8):e2426304. doi: 10.1001/jamanetworkopen.2024.26304. PMID 39115845